Literature DB >> 2246455

Are stressful life events risk factors for herpes zoster?

K Schmader1, S Studenski, J MacMillan, S Grufferman, H J Cohen.   

Abstract

To determine if psychologically stressful life events are risk factors for herpes zoster, we conducted a case-control study of zoster and self-reported recent negative life events and major changes in spousal relationships. The subjects were 101 healthy community-dwelling cases of zoster and 101 healthy controls matched for age, sex, and race and generated by random digit dialing. The Geriatric Scale of Recent Life Events was administered to case and control subjects, and additional questions were asked regarding the perception of the life event. The results showed that case subjects experienced negative life events significantly more often than subjects in the control groups in the 2 months before zoster onset by analysis of discordant pairs (26 versus 10, odds ratio 2.60, 95% confidence interval [CI] 1.13, 6.27, P = .012), 3 months before (29 versus 11, odds ratio 2.64, 95% CI 1.20, 6.04, P = .007), or 6 months before (35 versus 16, odds ratio 2.00, 95% CI 1.04, 3.93, P = .012). The mean number of total life events was significantly higher in cases at 6 months before zoster (case means = 2.64, control means = 1.82, P = .008), but there were no significant differences at 2, 3, or 12 months before. There were no significant differences between case subjects and control subjects for spousal events, or any given single life event. In conclusion, we found that whereas patients with herpes zoster experienced the same kinds of life events in the year preceding the illness as did control subjects, recent events perceived as stressful were significantly more common among patients with zoster.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2246455     DOI: 10.1111/j.1532-5415.1990.tb01497.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  24 in total

1.  Social stress and the reactivation of latent herpes simplex virus type 1.

Authors:  D A Padgett; J F Sheridan; J Dorne; G G Berntson; J Candelora; R Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

2.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

Review 3.  Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.

Authors:  Giovanni Gabutti; Paolo Bonanni; Michele Conversano; Guido Fanelli; Elisabetta Franco; Donato Greco; Giancarlo Icardi; Marzia Lazzari; Alessandro Rossi; Silvestro Scotti; Antonio Volpi
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

4.  Herpes zoster and postherpetic neuralgia: an examination of psychological antecedents.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2014-05

5.  Family history of zoster and risk of developing herpes zoster.

Authors:  Hung Fu Tseng; Margaret Chi; Peggy Hung; Rafael Harpaz; D Scott Schmid; Philip LaRussa; Lina S Sy; Yi Luo; Kimberly Holmquist; Harpreet Takhar; Steven J Jacobsen
Journal:  Int J Infect Dis       Date:  2017-11-13       Impact factor: 3.623

6.  Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.

Authors:  Michael R Irwin; Myron J Levin; Mark L Laudenslager; Richard Olmstead; Anne Lucko; Nancy Lang; Carmen Carrillo; Harold A Stanley; Michael J Caulfield; Adriana Weinberg; Ivan S F Chan; Jim Clair; Jeff G Smith; R D Marchese; Heather M Williams; Danielle J Beck; Patricia T McCook; Jane H Zhang; Gary Johnson; Michael N Oxman
Journal:  Clin Infect Dis       Date:  2013-02-13       Impact factor: 9.079

7.  Balanitis is a risk factor for herpes zoster.

Authors:  C-Y Hsu; C-L Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-18       Impact factor: 3.267

Review 8.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

10.  Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

Authors:  M J Levin; M N Oxman; J H Zhang; G R Johnson; H Stanley; A R Hayward; M J Caulfield; M R Irwin; J G Smith; J Clair; I S F Chan; H Williams; R Harbecke; R Marchese; S E Straus; A Gershon; A Weinberg
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.